Europe v US: the patentability of diagnostic claims

Patents covering the diagnosis of disease or personalised medicine often include claims in which the presence or level of a biomarker is correlated to a particular disease state. Such claims have been the focus of much attention following some landmark US Supreme Court decisions that have called into question their validity.